Additional information
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
₹ 3200
EX1920 t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE | |||||||
Specimen: | 3 mL (2 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Clinical history is mandatory. | ||||||
Stability: |
|
||||||
Method: | Real-Time PCR | ||||||
Comment: | |||||||
Report: | Contact us to know the TAT. | ||||||
Usage: | Chromosomal rearrangements can produce tumorigenic fusion genes. This mechanism is seen in 15-25% of Leukemias, Lymphomas & Sarcomas. Fusions can be produced by translocations, inversions, or deletions. Specific gene fusions in a patient’s tumor cells have an important bearing on the management & prognosis. This assay detects the MLL-AF9 fusion gene which is the most common MLL abnormality in AML. | ||||||
Doctor Specialty: | Oncologist | ||||||
Disease: | Leukemia | ||||||
Components: | |||||||
Courier Charges: | 0.00 | ||||||
Home Collection: | Available (*T&C Apply) | ||||||
Department: | MOLECULAR DIAGNOSTICS | ||||||
Pre Test Information: | Clinical history is mandatory. |
a division of exult cares pvt. ltd.
Reviews
There are no reviews yet.